Interleukin-12 gene polymorphisim in patients with giant cell arteritis, polymyalgia rheumatica and elderly-onset rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 27, Issue 1 SUPPL. 52, 2009, Pages

  Alvarez Rodriguez, Lorena ^a   Martínez Taboada, Victor Manuel ^a   López Hoyos, Marcos ^a   Mata, Cristina ^b   Fernandez Prieto, Lorena ^a   Agudo Bilbao, Mario ^a   Calvo, Jaime ^b   Ruiz Soto, Maria ^a   Rodriguez Valverde, Vicente ^a   Ruiz, Teresa ^b   Blanco, Ricardo ^a   Corrales, Alfonso ^c   Carrasco Marín, Eugenia ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b HOSPITAL SIERRALLANA   (Spain)

^c HOSPITAL DE LAREDO   (Spain)

Author keywords

Elderly onset rheumatoid arthritis; Giant cell arteritis; Interleukin 12; Polymyalgia rheumatica

Indexed keywords

CORTICOSTEROID; INTERLEUKIN 12; INTERLEUKIN 12P70; LONOMYCIN A; PHORBOL 13 ACETATE 12 MYRISTATE; PREDNISONE;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; GIANT CELL ARTERITIS; HUMAN; IN VITRO STUDY; INFLAMMATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SUPERNATANT;

3' UNTRANSLATED REGIONS; AGED; AGING; ARTHRITIS, RHEUMATOID; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GIANT CELL ARTERITIS; HUMANS; INTERLEUKIN-12; MALE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMYALGIA RHEUMATICA;

EID: 70450278797     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. PAWELEC G, SOLANA R: Immunosenescence. Immunol Today 1997; 18: 514-516
2. CASTLE SC: Clinical relevance of age-related immune dysfunction. Clin Infect Dis 2000; 31: 578-585 (Pubitemid 32289594)
3. MARTÍNEZ-TABOADA VM, GORONZY JJ, WEYAND CM: Conceptos actuales sobre la patogenia de la arteritis de células gigantes. Rev Esp Reumatol 1994; 2: 293-299
4. ARMONA J, RODRÍGUEZ VALVERDE V, GONZÁLEZ-GAY MA et al.: Arteritis de células gigantes. Estudio de 191 pacientes. Med Clin (Barc) 1995; 105: 734-737
5. HUSTON KA, HUNDER GG, LIE JT, KENNEDY KH, ELVEBACK LR: Temporal arteritis. A 25-year epidemiological, clinical and pathologic study. Ann Intern Med 1978; 88: 162-167
6. GONZÁLEZ-GAY MA, BLANCO R, RODRÍGUEZ-VALVERDE V et al.: Permanent visual loss and cerebrovascular accidents in giant cell arteritis. Predictors and response to treatment. Arthritis Rheum 1998; 41: 1497-1504
7. BRACK A, MARTÍNEZ-TABOADA VM, STANSON A, GORONZY JJ, WEYAND CM: Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999; 42: 311-317 (Pubitemid 29072849)
8. DASGUPTA B, HASSAN N: British Society for Rheumatology Guidelines Group. Giant cell arteritis: recent advances and guidelines for management. Clin Exp Rheumatology 2007; 25: S62-5.
9. MAKSIMOWICZ-MCKINNON K, HOFFMAN GS: Large vessel vasculitis. Clin Exp Rheumatology 2007; 25: S58-9.
10. CHUANG TY, HUNDER GG, ILSTRUP DM, KURLAND LT: Polymyalgia rheumatica: a 10- year epidemiologic and clinical study. Ann Intern Med 1982; 97: 672-680
11. FITO C, MARTÍNEZ-TABOADA VM, BLANCO R et al.: Long-term outcome of 162 patients with polymyalgia rheumatica. Arthritis Rheum 1998; 41: 9 (Suppl.): S356.
12. HUNDER GG, GORONZY JJ, WEYAND CM: Is seronegative RA in the elderly the same as polymyalgia rheumatica? Bull Rheum Dis 1994; 43: 1-3.
13. WEYAND CM, GORONZY JJ: Giant cell arteritis as an antigen driven disease. Rheum Dis Clin North Am 1995; 21: 1027-1039
14. TRINCHIERI G: Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994; 84: 4008-4027
15. WEYAND CM, TETZLAFF N, BJÖRNSSON J, BRACK A, YOUNGE B, GORONZY JJ: Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum 1997; 40: 19-26.
16. VAN VEEN T, CRUSIUS JB, SCHRIJVER HM et al.: Interleukin-12p40 genotype plays a role in the susceptibility to multiple sclerosis. Ann Neurol 2001; 50: 275.
17. MORAHAN G, HUANG D, YMER SI et al.: Linkage desequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet 2001; 27: 218-221
18. SEEGERS D, ZWIERS A, STROBER W, PEÑA AS, BOUMA G: A Taql polymorphism in the 3'UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun 2002; 3: 419-423
19. HUNDER GG, BLOCH DA, MICHEL BA et al.: The American College of Rheumatology 1990 criteria for the Classification of giant cell arteritis. Arthrirtis Rheum 1990; 33: 1122-1128
20. GONZÁLEZ-GAY MA, RODRÍGUEZ-VALVERDE V, BLANCO R et al.: Polymyalgia rheumatica without significantly increased ESR: A more benign syndrome. Arch Intern Med 1997; 157: 317-320
21. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324
22. HELLIER JP, ELIAOU JF, DAURES JP, SANY J, COMBE B: HLA-DRB1 genes and patients with late onset rheumatoid arthritis. Ann Rheum Dis 2001; 60: 531-533 (Pubitemid 32417431)
23. HUANG D, CANCILLA MR, MORAHAN G: Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit. Genes Immun 2000; 1: 515-20.
24. MARTÍNEZ-TABOADA V, BRACK A, HUNDER GG, GORONZY JJ, WEYAND CM: The inflammatory infiltrate in giant cell arteritis selects against B lymphocytes. J Rheumatol 1996; 23: 1011-1014
25. MARTÍNEZ-TABOADA V. BLANCO R, RODRIGUEZ-VALVERDE V: Arteritis de células gigantes. Seminarios de Reumatología 2000; 1: 141-157
26. YILMAZ V, YENTÜR SP, SARUHAN-DIRESKENELI G: IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine 2005; 30: 188-194
27. ROBLOT P, MOREL F, LELIEVRE E, GASCAN H, WIJDENES J, LECRON JC: Serum cytokine and cytokine receptor levels in patients with giant cell arteritis during corticosteroid therapy. J Rheumatol 1996; 23: 408-410
28. BLAIN H, ABDELMOUTTALEB I, BELMIN J et al.: Arterial wall production of cytokines in giant cell arteritis: results of a pilot study using human temporal artery cultures. J Gerontol A Biol Sci Med Sci 2002; 57: M241-5.
29. AMOLI MM, GONZÁLEZ-GAY MA, ZEGGINI E, SALWAY F, GARCIA-PORRUA C, OLLIER WER: Epistatic interactions between HLA-DRB1 and interleukin 4, but not interferon-gamma, increase susceptibility to giant cell arteritis. J Rheumatol 2004; 31: 2413-2417
30. GONZÁLEZ-GAY MA, HAJEER AH, DABABNEH A et al.: Interferon-gamma gene microsatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica. Clin Exp Rheumatol 2004; (Suppl. 36): S18-20.
31. HALL MA, MCGLINN E, COAKLEY G et al.: Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun 2000; 1: 219-224
32. LATSI P, PANTELIDIS P, VASSILAKIS D, SATO H, WELSH K, DU BOIS RM: Analysis of IL-12 p40 subunit gene and IFN-γ G5644A polymorphisms in idiopathic pulmonary fibrosis. Respir Res 2003; 4: 6.
33. WARLE MC, FARHAN A, METSELAAR HJ et al.: Are cytokine polymorphisms related to in vitro cytokine production profiles? Liver Transpl 2003; 9: 170-181
34. OROZCO G, GONZALEZ-GAY MA, PACO L et al.: Interleukin 12 (IL12B) and interleukin 12 receptor (IL12RB1) gene polymorphisms in rheumatoid arthritis. Human Immunol 2005; 66: 711-715
35. SARUHAN-DIRESKENELI G, BIÇAKÇIGIL M, YILMAZ V et al.: Interleukin (IL)-12, IL-2, and IL-6 gene polymorphisms in Takayasu's arteritis from Turkey. Human Immunol 2006; 67: 735-740
36. KERR GS, HALLAHAN CW, GIORDANO J et al.: Takayasu arteritis. Ann Intern Med 1994; 120: 919-929
37. VERMA DK, TRIPATHY NK, VERMA NS, TIWARI S: Interleukin 12 in Takayasu's arteritis: plasma concentrations and relationship with disease activity. J Rheumatol 2005; 32: 2361-2363
38. PARK MC, LEE SW, PARK YB, LEE SK: Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis. Rheumatology 2006; 45: 545-548